Carbamazepine: a 'blind' assessment of CYP-associated metabolism and interactions in human liver-derivedin vitrosystems-Reference-Cited by-同舟云学术

Carbamazepine: a 'blind' assessment of CYP-associated metabolism and interactions in human liver-derivedin vitrosystems

Published:2001-01 Issue:6 Volume:31 Page:321-343
ISSN:0049-8254
Container-title:Xenobiotica
language:en
Short-container-title:Xenobiotica

Author:

Pelkonen O.,Myllynen P.,Taavitsainen P.,Boobis A. R.,Watts P.,Lake B. G.,Price R. J.,Renwick A. B.,Gómez-Lechón M.-J.,Castell J. V.,Ingelman-Sundberg M.,Hidestrand M.,Guillouzo A.,Corcos L.,Goldfarb P. S.,Lewis D. F. V.

Publisher

Informa UK Limited

Subject

Health, Toxicology and Mutagenesis,Pharmacology,Toxicology,Biochemistry,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.1080/00498250110055479

Reference37 articles.

1. A simple and sensitive assay of 7-ethoxycoumarin deethylation

2. Culture of precision-cut liver slices: Effect of some peroxisome proliferators

3. Carbamazepine treatment induces the CYP3A4 catalysed sulphoxidation of omeprazole, but has no or less effect on hydroxylation via CYP2C19

4. A new carbamazepine metabolite in uraemic filtrate

5. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

Cited by 58 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of a Safe and Tolerable Carbamazepine Dosing Paradigm that Facilitates Effective Evaluation of CYP3A4 Induction;Clinical Pharmacology & Therapeutics;2024-06-12

2. Formation of potentially toxic metabolites of drugs in reactions catalyzed by human drug-metabolizing enzymes;Archives of Toxicology;2024-03-23

3. Assessment of the CYP3A4 Induction Potential by Carbamazepine: Insights from Two Clinical DDI Studies and PBPK Modeling;Clinical Pharmacology & Therapeutics;2024-01-08

4. Alternatives to rifampicin: A review and perspectives on the choice of strong CYP3A inducers for clinical drug–drug interaction studies;Clinical and Translational Science;2022-07-25

5. Pharmacokinetics of the CYP3A4 and CYP2B6 Inducer Carbamazepine and Its Drug–Drug Interaction Potential: A Physiologically Based Pharmacokinetic Modeling Approach;Pharmaceutics;2021-02-17